New Siemens–Illumina partnership targets clinical infectious disease testing using next-generation sequencing
Siemens Healthcare Diagnostics and Illumina have entered into a partnership aimed at setting new standards in the use of next-generation sequencing for the rapid, accurate identification of patients’ infectious disease states and potential treatment paths. Through this agreement, the companies plan to make existing Siemens molecular HIV tests compatible with the recently launched Illumina MiSeq […]